Press Release & Publications

2019-05-24

Phase 2a SURPH Trial for AG-86893

May 24th, 2019 Allgenesis In The News: A […]
Do you like it?
Read more
2019-05-04

Allgenesis Presented Three Posters at ARVO 2019

May 4th, 2019 Allgenesis attended the 20 […]
Do you like it?
Read more
2019-02-13

Allgenesis Receives Notice of Acceptance of Australian Patent for Fusion Protein of VEGF Trap and Disintegrin

February 13th, 2019 Allgenesis Biotherap […]
Do you like it?
Read more
2019-01-03

Allgenesis has been Granted Australian Patent for Multi-Tyrosine Kinase Inhibitor in Ophthalmic Suspension and its use for Treating Ocular Surface Diseases

January 3rd, 2019 Allgenesis Biotherapeu […]
Do you like it?
Read more
2018-12-28

Allgenesis Biotherapeutics Inc. has been Granted U.S. Patent for Pterygium Treatment Using Multi-Tyrosine Kinase Inhibitor in Ophthalmic Suspension

December 28th, 2018 Allgenesis Biotherap […]
Do you like it?
Read more
2018-11-01

Allgenesis Receives Notice of Acceptance of Australian Patent for Novel Disintegrin Variants

November 1st, 2018 Allgenesis Biotherape […]
Do you like it?
Read more
Load more